Despite looking to have taken a big step back from cell therapy work this year, Novartis hopes to be first to market a new CAR-T med as it plans to file early…

UniQure has posted fresh data linking its hemophilia B gene therapy to the near-cessation of spontaneous bleeding.

Pfizer’s longtime official Maddaluna is retiring as EVP, Thomas Willemsen will lead GSK China, Taro taps Sun Pharma CFO as new CEO. Plus more hirings, firings…

Japanese Big Pharma Takeda and VC Lightstone have come together to launch Cerevance, a newco focused on neuroscience R&D for neurological and psychiatric…

Amryt, which is chaired by Shire founder Harry Stratford, has secured €20 million to fund a pivotal trial of its lead candidate in epidermolysis bullosa.

A litmus test of President-elect Donald Trump's plans for the FDA will come when the agency's commissioner hands in his resignation letter in the…

In this week's EuroBiotech Report, Kymab raises $100 million, AstraZeneca, Bicycle pen pact, Heptares to buy G7 and more.

Facebook and Napster billionaire Sean Parker has seen his Institute for Cancer Immunotherapy join forces with the Cancer Research Institute (CRI) to work on…

Biotech